Infective endocarditis in the real world: The Italian Registry of Infective Endocarditis (Registro Italiano Endocardite Infettiva - RIEI)

Journal of Cardiovascular Medicine

Volumn 9, Issue 5, 2008, Pages 508-514

  Cecchi, Enrico ^a   Imazio, Massimo ^a   De Rosa, Francesco Giuseppe ^b   Chirillo, Fabio ^c   Enia, Francesco ^d   Pavan, Daniela ^e   Cecconi, Moreno ^f   Squeri, Angelo ^g   Trinchero, Rita ^a  

^a MARIA VITTORIA HOSPITAL   (Italy)

^b AMEDEO DI SAVOIA HOSPITAL   (Italy)

^c CA FONCELLO HOSPITAL   (Italy)

^d VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^e San Vito al Tagliamento Hospital   (Italy)

^f OSPEDALI RIUNITI   (Italy)

^g UNIVERSITY OF PARMA   (Italy)

Author keywords

Endocarditis; Management; Prognosis; Prophylaxis; Registry; Therapy

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; BACTERIAL ENDOCARDITIS; CLINICAL FEATURE; DEMOGRAPHY; DISEASE PREDISPOSITION; DISEASE REGISTRY; HEART DISEASE; HUMAN; INFORMATION PROCESSING; ITALY; KNOWLEDGE; PATHOGENESIS; PROGNOSIS; REVIEW; SURGICAL TECHNIQUE;

ENDOCARDITIS; HUMANS; ITALY; REGISTRIES; RISK FACTORS;

EID: 42149172587     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e3282f20ae6     Document Type: Review

References (41)

1. Durack DT, Crawford MH. Infective endocarditis. Cardiol Clin 2003; 21:159-166.
2. Cabell CH, Jollis JG, Peterson GE, Corey GR, Anderson DJ, Sexton DJ, et al. Changing patient characteristic and the effect on mortality in endocarditis. Arch Intern Med 2002; 162:90-94.
3. Netzer RO, Altwegg SC, Zollinger E, Tauber M, Carrel T, Seiler C. Infective endocarditis: determinants of long term outcome. Heart 2002; 88:61-66.
4. Quagliarello V. Infective endocarditis. Global, regional, and future perspectives. JAMA 2005; 293:3061-3062.
5. Cecchi E, Imazio M, Trinchero R. The changing face of infective endocarditis. Heart 2006; 92:10-27.
6. Fowler VG Jr, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, et al., ICE Investigators. Staphylococcus aureus endocarditis. A consequence of medical progress. JAMA 2005; 293:3012-3021.
7. Oakley CM, Hall RJC. Endocarditis: problems-patients being treated for endocarditis and not doing well. Heart 2001; 85:470-474.
8. Moreillon P. Infective endocarditis. Lancet 2004; 363:139-149.
9. Habib G. Management of infective endocarditis. Heart 2006; 92:124-130.
10. Cabel CH, Peterson GE. Factors affecting long-term mortality in endocarditis: the bugs, the drugs, the knife or the patients? Am Heart J 2001; 141:6-8.
11. Steckelberg JM, Melton LJ III, Ilstrup DM, Rouse MS, Wilson WR. Influence of referral bias on the apparent clinical spectrum of infective endocarditis. Am J Med 1990; 88:582-588.
12. Von Reyn CF, Levy BS, Arbelt RD, Friedland G, Crumpacker CS. Infective endocarditis: an analysis based on strict case definition. Ann Intern Med 1981; 94:505-517.
13. Durack DT, Lukes AS, Bright DK, and Duke Endocarditis Service. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med 1994; 96:200-209.
14. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30:633-638.
15. Delahaye F, Goulet V, Lacassin F, Ecochard R, Selton-Suty C, Hoen B, et al. Characteristics of infective endocarditis in France in 1991: a 1-year survey. Eur Heart J 1995; 16:394-401.
16. Van der Meer JT, Thompson J, Valkenburg HA, Michel MF. Epidemiology of bacterial endocarditis in the Netherlands. Arch Intern Med 1992; 152:1863-1868.
17. Hoen B, Alla F, Selton-Suty C, Beguinot I, Bouvet A, Briancon S, et al., Association pour l'Etude et la Prevention de l'Endocardite Infectieuse (AEPEI) Study Group. Changing profile of infective endocarditis. Results of a 1-year survey in France. JAMA 2002; 288:75-81.
18. Cecchi E, Forno D, Imazio M, Migliardi A, Gnavi R, Dal Conte I, Trinchero R, Piemonte Infective Endocarditis Study Group. New trends in the epidemiology and clinical features of infective endocarditis in Piemonte: results from a multicenter prospective study in Piemonte. Ital Heart J 2004; 5:249-256.
19. Hogevik H, Olaison L, Anderson R, Lindberg J, Alestig K. Epidemiologic aspects of infective endocarditis in an urban population: a 5 year prospective study. Medicine (Baltimore) 1995; 74:324-339.
20. Berlin JA, Abrutyn E, Strom BL, Kinman JL, Levison ME, Korzeniowski OM, et al. Incidence of infective endocarditis in the Delawere Valley, 1988-1990. Am J Cardiol 1995; 76:933-936.
21. Heiro M, Helenius H, Makila S, Hohenthal U, Savunen T, Engblom E, et al. Infective endocarditis in a Finnish teaching hospital: a study on 326 episodes treated during 1980-2004. Heart 2006; 92:1457-1462.
22. Tleyjeh IM, Steckelberg JM, Murad HS, Anavekar NS, Ghomrawi HM, Mirzoyev Z, et al. Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. JAMA 2005; 293:3022-3028.
23. Tornos MP, Olona M, Permanyer-Miralda G, Almirante B, Evangelista A, Soler-Soler J. Is the clinical spectrum and prognosis of native valve infective endocarditis in nonaddicts changing? Eur Heart J 1995; 16:1686-1691.
24. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546-1554.
25. Martin-Davila P, Fortun J, Navas E, Cobo J, Jimenez-Mena M, Moya JL, Moreno S. Nosocomial endocarditis in a tertiary hospital: an increasing trend in native valve cases. Chest 2005; 128:772-779.
26. Cecchi E, Imazio M, Tidu M, Forno D, De Rosa FG, Dal Conte I, et al. Infective endocarditis in drug addicts: role of HIV infection and diagnostic accuracy of Duke criteria. J Cardiovasc Med (Hagerstown) 2007; 8:169-175.
27. Mirò JM, Del Rio A, Mestres CA. Infective endocarditis in intravenous drug abusers and HIV-1 infected patients. Cardiol Clin 2003; 21:1-15.
28. Wilson W, Thaubert KA, Gewitz M, Lockhart PB, Baddour LM, et al. Prevention of infective endocarditis. A guidelines from the American Heart Association rheumatic fever, endocarditis, and Kawasaki disease Committee, Council on cardiovascular disease in the young, and the Council on clinical cardiology, Council on cardiovascular surgery and anesthesia, and the quality of care and outcome research interdisciplinary working group. Circulation 2007; 116:1736-1754.
29. Horstkotte D, Follath F, Gutschik E, Lengyel M, Oto A, Pavie A, et al., Task Force Members on Infective Endocarditis of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG); Document Reviewers. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. Eur Heart J 2004; 25:267-276.
30. Ashrafian H, Bogle RG. Antimicrobial prophylaxis for endocarditis: emotion or science? Heart 2007; 93:5-6.
31. Strom BL, Abrutyn E, Berlin JA, Kinman JL, Feldman RS, Stolley PD, et al. Dental and cardiac risk factors for infective endocarditis. A population-based, case-control study. Ann Intern Med 1998; 129:761-769.
32. Houpikian P, Raoult D. Blood culture-negative endocarditis in a reference center: etiologic diagnosis of 348 cases. Medicine (Baltimore) 2005; 84:162-173.
33. Lamas CC, Eykyn SJ. Blood culture negative endocarditis: analysis of 63 cases presenting over 25 years. Heart 2003; 89:258-262.
34. Millar B, Moore J, Mallon P, Xu J, Crowe M, Mcclurg R, et al. Molecular diagnosis of infective endocarditis - a new Duke's criterion. Scand J Infect Dis 2001; 33:673-680.
35. Enia F, Di Stefano G, Floresta AM, Matassa C. New etiologies responsible for infective endocarditis with negative blood cultures. Ital Heart J Suppl 2005; 6:128-134.
36. Bayer AS, Bolger AF, Taubert KA, Wilson W, Steckelberg J, Karchmer AW, et al. Diagnosis and management of infective endocarditis and its complications. Circulation 1998; 98:2936-2948.
37. Cecchi E, Trinchero R, Imazio M, Forno D, Dal Conte I, Lipani F, et al., Piedmont Infective Endocarditis Study Group. Are the Duke criteria really useful for the early bedside diagnosis of infective endocarditis? Results of a prospective multicenter trial. Ital Heart J 2005; 6:41-48.
38. Delahaye F, Ecochard R, de Gevigney G, Barjhoux C, Malquarti V, Saradarian W, Delaye J. The long term prognosis of infective endocarditis. Eur Heart J 1995; 16 (Suppl B):48-53.
39. Olaison L, Petterson G. Current best practices and guidelines indication for surgical intervention in infective endocarditis. Cardiol Clin 2003; 21:235-251.
40. Alexiou C, Langley SM, Stafford H, Lowes JA, Livesey SA, Monro JL. Surgery for active culture-positive endocarditis: determinants of early and late outcome. Ann Thorac Surg 2000; 69:1448-1454.
41. Bayer AS, Scheld WM. Infective endocarditis. In: Mandell GN, Bennett GE, Dolin R, editors. Principles and practice of infectious diseases, 5th edn. Philadelphia: Churcill Livingstone; 2000. pp. 857-902.